©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 112349
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112349
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112349
Table 5 Association between rs73262897 with histological and immunohistochemical subtypes of breast cancer, n (%)
| rs73262897 G>A | Cases | Control | Model comparison | OR (95%CI) | P value | ||
| Breast cancer ductal | |||||||
| Genotype | - | n = 37 | n = 215 | - | G/G vs G/A | 1.0970 (0.4683-2.5696) | 0.8311 |
| G/G | 29 (78) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 8 (22) | 43 (20) | - | G vs A | 1.0370 (0.4678-2.2990) | 0.9287 | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 66 (89) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 8 (11) | 45 (10) | L-ad | - | - | ||
| Breast cancer lobular | |||||||
| Genotype | - | n = 13 | n = 215 | - | G/G vs G/A | - | - |
| G/G | 10 (77) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 3 (23) | 43 (20) | - | G vs A | - | - | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 23 (88) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 3 (12) | 45 (10) | L-ad | - | - | ||
| Breast cancer mixed | |||||||
| Genotype | - | n = 5 | n = 215 | - | G/G vs G/A | - | - |
| G/G | 2 (40) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 3 (60) | 43 (20) | - | G vs A | - | - | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 7 (70) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 3 (30) | 45 (10) | L-ad | - | - | ||
| Breast cancer HR+/LA | |||||||
| Genotype | - | n = 36 | n = 215 | - | G/G vs G/A | 1.5295 (0.6857-3.4119) | 0.2992 |
| G/G | 26 (72) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 10 (28) | 43 (20) | - | G vs A | 1.3799 (0.6611-2.8802) | 0.3910 | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 62 (86) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 10 (14) | 45 (10) | L-ad | - | - | ||
| Breast cancer TP/LB | |||||||
| Genotype | - | n = 13 | n = 215 | - | G/G vs G/A | - | - |
| G/G | 10 (77) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 3 (23) | 43 (20) | - | G vs A | - | - | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 23 (88) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 3 (12) | 45 (10) | L-ad | - | - | ||
| Breast cancer HER2+ | |||||||
| Genotype | - | n = 9 | n = 215 | - | G/G vs G/A | - | - |
| G/G | 7 (78) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 2 (22) | 43 (20) | - | G vs A | - | - | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 16 (89) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 2 (11) | 45 (10) | L-ad | - | - | ||
| Breast cancer TN | |||||||
| Genotype | - | n = 5 | n = 215 | - | G/G vs G/A | - | - |
| G/G | 5 (100) | 171 (80) | MC | G/G vs A/A | - | - | |
| G/A | 0 (0) | 43 (20) | - | G vs A | - | - | |
| A/A | 0 (0) | 1 (0) | Do | G/G vs G/A + A/A | - | - | |
| Allele | - | Re | G/G + G/A vs A/A | - | - | ||
| G | 10 (100) | 385 (90) | OD | G/G + A/A vs G/A | - | - | |
| A | 0 (0) | 45 (10) | L-ad | - | - | ||
- Citation: Victorio-De Los Santos M, Rodríguez-López AA, Gutiérrez-Franco J, Rodríguez-Trejo A, Nieves-López ZF, Torres-Valadez R, Zepeda-Carrillo EA, Flores-Reyes MF, Ayón-Pérez MF, Vázquez-Reyes A. Single-nucleotide variants in microRNAs associated with breast cancer in women from western Mexico. World J Clin Oncol 2025; 16(11): 112349
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/112349.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.112349